person

Ava D.

Country
France
Department
Maladies Infectieuses et Tropicales

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
5
Sites with multiple studies

Has run more than one trial at 5 of 27 partner sites.

Specializations

Nontuberculous Mycobacterial Infections

Focused on pulmonary disease caused by Mycobacterium avium complex in newly diagnosed adult patients.

  • Diagnosis and management of NTM lung disease
  • Antimicrobial regimens for MAC infections
  • Outcomes of treatment in immunocompetent versus immunocompromised hosts

Research conducted at major Parisian hospitals supports therapeutic optimization for this emerging infection.

Viral Hepatitis and HIV

Investigates chronic infections with Hepatitis B virus, Hepatitis C virus and Human Immunodeficiency Virus in diverse patient populations.

  • Long‑term antiviral efficacy and safety
  • Co‑infection management strategies
  • Impact of viral suppression on liver disease progression

Studies leverage the expertise of Assistance Publique – Hôpitaux de Paris for multicenter enrollment.

Sepsis and Critical Care Infectious Diseases

Addresses severe bacterial infections and septic shock in adult intensive‑care units.

  • Pathogen‑directed antibiotic therapy in ICU patients
  • Biomarker‑guided treatment algorithms
  • Outcomes of invasive mechanical ventilation related infections

Collaboration with Hopital Beaujon provides access to a high‑volume critical‑care cohort.

Autoimmune and Inflammatory Disorders

Specializes in systemic autoimmune diseases such as primary Sjögren's syndrome and ANCA‑associated vasculitis.

  • Immunomodulatory treatment efficacy
  • Clinical phenotyping of organ‑specific involvement
  • Longitudinal monitoring of disease activity

Research integrates rheumatology and infectious disease expertise to optimize patient care.

Amyloidosis and Neuropathy

Explores hereditary transthyretin amyloidosis with polyneuropathy and related cardiomyopathy.

  • Genotype‑phenotype correlation in ATTR
  • Therapeutic impact of TTR stabilizers
  • Neurological and cardiac outcome measures

Studies aim to define disease‑modifying strategies for this rare systemic disorder.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.